Ignite Creation Date:
2025-12-24 @ 7:24 PM
Ignite Modification Date:
2026-01-20 @ 11:00 PM
Study NCT ID:
NCT00463203
Status:
COMPLETED
Last Update Posted:
2011-06-29
First Post:
2007-04-18
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Bevacizumab and Irinotecan for Patients With Primary Brain Tumors and Progression After Standard Therapy
Sponsor:
Rigshospitalet, Denmark
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
BI-Brain-01
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
None
Responsible Party Affiliation:
Old Name:
Ulrik Lassen
Old Organization:
Rigshospitalet